Cite
HARVARD Citation
Lee, J. et al. (2018). A novel, topical, nonsteroidal, TRPV1 antagonist, PAC-14028 cream improves skin barrier function and exerts anti-inflammatory action through modulating epidermal differentiation markers and suppressing Th2 cytokines in atopic dermatitis. Journal of dermatological science. 91 (2), pp. 184-194. [Online].